Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance.
- NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_assertion description "[EGFR expression but not HER2 gene amplification was significantly associated with poor overall survival in patients with type II EC, (EGFR, median survival 20 vs 33 months, P=0.028; HER2, median survival 18 vs 29 months, P=0.113) and EGFR expression retained prognostic independence when adjusting for histology, stage, grade, and age (EGFR, P=0.0197; HER2, P=0.7855).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance.
- NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_assertion evidence source_evidence_literature NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance.
- NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_assertion SIO_000772 19088718 NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance.
- NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_assertion wasDerivedFrom befree-20140225 NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance.
- NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_assertion wasGeneratedBy ECO_0000203 NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP168291.RAvZfm5JLp6T6uFVgYCB32zdr0odUE1HkSjRnDlwGxhWc130_provenance.